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Regulation of gene expression in the 
bovine blastocyst by colony stimulating factor 2
Manabu Ozawa1,2, Miki Sakatani3, Kyle B. Dobbs1,4, Jasmine Kannampuzha‑Francis1 and Peter J. Hansen1*
Abstract 
Background: Colony stimulating factor 2 can have multiple effects on the function of the preimplantation embryo 
that include increased potential to develop to the blastocyst stage, reduced apoptosis, and enhanced ability of inner 
cell mass (ICM) to remain pluripotent after culture. The objective of the current experiment was to identify genes 
regulated by CSF2 in the ICM and trophectoderm (TE) of the bovine blastocyst with the goal of identifying possible 
molecular pathways by which CSF2 increases developmental competence for survival. Embryos were produced 
in vitro and cultured from Day 6 to 8 in serum‑free medium containing 10 ng/ml recombinant bovine CSF2 or vehicle. 
Blastocysts were harvested at Day 8 and ICM separated from TE by magnetic‑activated cell sorting. RNA was purified 
and used to prepare amplified cDNA, which was then subjected to high‑throughput sequencing using the SOLiD 4.0 
system. Three pools of amplified cDNA were analyzed per treatment.
Results: The number of genes whose expression was regulated by CSF2, using P < 0.05 and >1.5‑fold difference as 
cut‑offs, was 945 in the ICM (242 upregulated by CSF2 and 703 downregulated) and 886 in the TE (401 upregulated by 
CSF2 and 485 downregulated). Only 49 genes were regulated in a similar manner by CSF2 in both cell types. The three 
significant annotation clusters in which genes regulated by ICM were overrepresented were related to membrane 
signaling. Genes downregulated by CSF2 in ICM were overrepresented in several pathways including those for ERK 
and AKT signaling. The only significant annotation cluster containing an overrepresentation of genes regulated by 
CSF2 in TE was for secreted or extracellular proteins. In addition, genes downregulated in TE were overrepresented in 
TGFβ and Nanog pathways.
Conclusions: Differentiation of the blastocyst is such that, by Day 8 after fertilization, the ICM and TE respond differ‑
ently to CSF2. Analysis of the genes regulated by CSF2 in ICM and TE are suggestive that CSF2 reinforces developmen‑
tal fate and function of both cell lineages.
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Background
Maternally-derived signals called embryokines can alter 
developmental phenotype of the preimplantation embryo 
immediately or later during pre-natal or post-natal life 
[1, 2]. CSF2 is one of the best-studied embryokines and 
has been shown to affect developmental processes in 
preimplantation embryo of the cow, mouse, human, and 
pig [2, 3]. In the cow, the species studied here, treatment 
of embryos with CSF2 from Day 5–7 of development 
can increase the proportion of embryos becoming blas-
tocysts [4–6], block apoptosis of morula-stage embryos 
in response to heat shock [7], improve ability of isolated 
inner cell mass (ICM) to survive passage while remain-
ing in a pluripotent state [6], increase the proportion of 
embryos developing to term after transfer into recipient 
females [8, 9] and result in calves with increased growth 
rate after birth [10].
The objective of the current experiment was to identify 
genes regulated by CSF2 in the ICM and trophectoderm 
(TE) of the bovine blastocyst with the goal of identifying 
possible molecular pathways by which CSF2 increases 
developmental competence for survival.
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Methods
Data were obtained as part of an experiment on gene 
expression in isolated ICM and TE of the bovine blasto-
cyst that was reported earlier [11]. The earlier paper con-
tained data from control embryos only and the current 
report details additional information about differences in 
gene expression between control embryos and embryos 
treated with CSF2 from Day 6 to 8 of development.
Embryo production, isolation of ICM and TE, and RNA‑Seq
These procedures were described in detail earlier [11]. 
Briefly, bovine embryos were produced by fertilizing 
slaughterhouse-derived oocytes with Percoll-purified 
spermatozoa from a pool of frozen-thawed semen from 
three bulls. Fertilization proceeded for 18–20  h and 
then embryos were cultured in 50  µl SOF-BE1 medium 
[12] at 38.5  °C in a humidified atmosphere of 5  % CO2 
and 5  % O2 with the balance N2. At Day 6, an addi-
tional 5 µl culture medium was added containing either 
medium alone (control) or, for the CSF2 group, 110 ng/
ml recombinant bovine CSF2 (CIBA-GEIGY, Basel, Swit-
zerland) to achieve a final CSF2 concentration of 10 ng/
ml CSF2. Blastocysts were harvested at Day 8 after ferti-
lization and used to prepare preparations of ICM and TE 
using magnetic-activated cell sorting as described [11]. 
Three separate pools of TE and ICM for each treatment 
were obtained. Each pool was prepared using 88–102 
blastocysts.
Total RNA isolated from each pool of embryonic cells 
was used to prepare amplified cDNA using the Ovation 
RNA-Seq kit (NuGen Technology, San Carlos, CA, USA). 
Barcoded fragment libraries were constructed using 
the SOLiD™ v4 fragment library kit. Amplified bead-
bound libraries were clonally amplified by emulsion PCR 
according to the Applied Biosystems SOLiD™ 4 Systems 
Templated Bead Preparation Guide (Applied Biosystems, 
Foster City, CA, USA). Clonally amplified template DNA 
were P2-enriched and extended with a bead linker by ter-
minal transferase. Approximately 600–700 M beads were 
deposited on each slide and sequenced using ‘sequencing 
by ligation’ chemistry and the 50 × 5 bp protocol on the 
SOLiD™ v4 sequencer (Applied Biosystems) at the Inter-
disciplinary Center for Biotechnology Research, Univer-
sity of Florida. Results were obtained as color space fasta 
files. Processing of reads was described earlier [11]. A 
total of 64.4 % or 595 million reads were mapped success-
fully. Data were deposited as Submission DRA000504 in 
the DDBJ Sequence Read Archive at http://www.ddbj.nig.
ac.jp/index-e.html.
Analysis of RNA‑Seq data
The number of mapped reads for each individual gene 
was counted using the HTSeq tool (http://www-huber.
embl.de/users/anders/HTSeq/doc/overview.html) with 
intersection-nonempty mode. The DESeq package [13] 
in R was used to determine treatment effects on gene 
expression. Treatment effects were determined by mak-
ing the following comparisons: ICM-control vs ICM-
CSF2 and TE-control vs TE-CSF2. Two separate sets of 
differentially expressed genes were identified. The first 
included those with a P value of <0.05 and a minimum 
fold-change of >1.5 or <0.66 (CSF2/control) and the sec-
ond included the same fold-change cut-off and a P < 0.05 
after adjustment for a 2 % false discovery rate using the 
Benjamini-Hochberg procedure [14].
Bioinformatics
The differentially expressed genes in TE and ICM were 
analyzed by the Database for Annotation, Visualization 
and Integrated Discovery (DAVID; (DAVID Bioinfor-
matics Resources 6.7, http://david.abcc.ncifcrf.gov/) [15]. 
Ambiguous gene identifiers were submitted to the gene 
conversion tool to create DAVID gene names. The DAVID 
database was queried to identify functional annotation 
terms and clusters in which differentially expressed genes 
were overrepresented. Clusters of annotation terms with 
Benjamini-Hochberg corrected P values of <0.05 were 
identified. Lists of upregulated and downregulated genes 
in ICM and TE were also separately analyzed for overrep-
resentation of genes in SuperPaths using GeneAnalytics 
(https://ga.genecards.org). SuperPaths are a collection of 
1073 unified pathways generated from multiple pathway 
sources using nearest neighbor graphing and hierarchical 
clustering [16]. All SuperPaths with an adjusted P value 
of <0.0001 are reported as well as selected paths with an 
adjusted P value of <0.05. Lists of differentially expressed 
genes in ICM and TE were separately uploaded to Inge-
nuity Pathway Analysis (IPA, Qiagen, Redwood City, CA, 
USA) for 1) clustering of differentially expressed genes 
into diseases and functions predicted to be changed as 
a result of differential gene expression and 2) identifica-
tion of putative transcriptional regulators of differentially 
expressed genes. A function was predicted to be changed 
when the activation z-score ≥2.0. For upstream regula-
tors, transcriptional regulators that were predicted to be 
activated or inhibited by CSF2 (i.e., activation z-score 
≥2.0) are reported.
Results
Genes regulated by CSF2
The effects of CSF2 on gene expression are described in 
Additional file  1. The number of genes whose expres-
sion was regulated by CSF2, using P  <  0.05 and >1.5-
fold or <0.66-fold difference as cut-offs, was 945 in the 
ICM (242 upregulated by CSF2 and 703 downregulated) 
and 886 in the TE (401 upregulated by CSF2 and 485 
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downregulated). A total of 74 genes were regulated by 
CSF2 in both ICM and TE (Additional file 1). Of these, 
9 were upregulated by CSF2 in both cell types, 40 were 
downregulated by CSF2 in both cell types, 13 were 
upregulated by CSF2 in ICM and downregulated in TE 
and 12 were downregulated in ICM and upregulated in 
TE.
When a more stringent criterion was applied, an 
adjusted P value of <0.05 after performing a Benjamini-
Hochberg correction for a false discovery rate of 2  %, 
CSF2 changed expression of 25 genes in the ICM (8 
upregulated and 17 downregulated by CSF2) and 23 
genes in the TE (14 upregulated and 9 downregulated). 
The list of these genes for ICM is shown in Table 1. The 
largest increase in expression caused by CSF2 was for 
FRMPD3 (14.7-fold), NDNF (13.3-fold), LAPTM5 (12.3-
fold) and an ortholog of OLFR1239 (8.5-fold). The larg-
est decrease in expression was for a bovine ortholog 
of MYADM (undetectable in cells from CSF2-treated 
embryos), olfactory receptor, family 5, subfamily T like 
(0.11control/CSF2 or a 19.9-fold decrease), CMYA5 
(19.7-fold decrease) and another family 5 olfactory recep-
tor (OR5T2; 8.8-fold decrease).
Results for genes regulated by CSF2 in TE after cor-
recting for multiple testing are summarized in Table  2. 
The largest increase in expression caused by CSF2 was 
for CLIC6 (undetectable in the absence of CSF2 and pre-
sent in CSF2-treated TE), the olfactory receptor OR5AN1 
(16.2-fold), CSN3 (13.1-fold; also upregulated 4.6-fold in 
ICM) and a uncharacterized gene (11.5-fold). The larg-
est decrease was for a gene orthologous to interferon-
regulatory factor (19.2-fold decrease), NPY1R (17.8-fold 
decrease), PAQR7 (17.0-fold decrease) and VAV3 (4.8-
fold decrease).
Functional annotation of differentially expressed genes
A total of 671 differentially expressed genes in the ICM 
was annotated by DAVID. There were three annotation 
clusters having Benjamini-Hochberg adjusted P val-
ues <0.05 (Additional file 2). These included a cluster of 
194 genes related to membrane signaling (enrichment 
score = 4.26), another of 254 genes related to membrane 
and extracellular space (enrichment score = 2.94) and a 
cluster of 30 genes related to sensory perception (enrich-
ment score = 2.36). Of note was the large number of dif-
ferentially expressed genes associated with G-protein 
coupled receptor protein signaling pathway (67 genes) 
and olfactory receptor activity (48 genes, adjusted P 
value  =  0.013). CSF2 increased expression of some 
olfactory genes and decreased expression of others. For 
example, LOC100294956 (olfactory receptor 4A47) was 
increased 8.48-fold and OR5T2 was decreased 9.09-fold 
(Table 1). The absolute number of reads for most putative 
olfactory receptor genes was low (<5).
For differentially expressed genes in the TE, 648 dif-
ferentially expressed genes were annotated by DAVID. 
The only cluster of pathways with a Benjamini-Hoch-
berg adjusted P value <0.05 was for 108 genes related 
to secreted or extracellular proteins (enrichment 
score = 4.22) (Additional file 2).
GeneAnalytics was used to identify SuperPaths in 
which genes regulated by CSF2 were overrepresented. 
Using a P value of 0.001 as a cutoff, there were no 
SuperPaths identified for genes upregulated by CSF2 
in ICM. Among genes downregulated by CSF2 were 
those in the ERK signaling, integrin pathway, vis-
ual cycle and AKT signaling (Table  3). There were 11 
Superpaths in which genes upregulated by CSF2 in TE 
were overrepresented (Table  4). Among these were 
those for apoptotic pathways in synovial fibroblasts, 
G protein signaling Ras family GTPases in kinase cas-
cades, and ERK signaling. There were four SuperPaths 
containing genes downregulated by CSF2 in TE with 
P  <  0.001 including for CREB pathway, actin nuclea-
tion by ARP-WASP complex, Akt signaling, and ERK 
signaling (Table 5). In addition, there were two Super-
Paths related to pluripotency and differentiation of the 
blastocyst (TGF-β, Nanog in mammalian ESC pluripo-
tency) that contained an overrepresentation of down-
regulated genes in the TE at P < 0.05.
Sets of genes that were differentially expressed in ICM 
and TE were separately subjected to analysis by IPA to 
determine 1) diseases and functions predicted to be acti-
vated or inhibited as a result of changes in gene expres-
sion caused by CSF2 and 2) transcriptional regulators that 
were postulated to be activated or inhibited in response 
to CSF2. For ICM, a total of 22 functions (many overlap-
ping) were predicted to change in response to alterations 
in gene expression caused by CSF2 (Additional file 3). In 
all cases, the function was predicted to decrease. Among 
these functions were 9 related to phagocytosis or cell 
movement, 2 related to changes in cell morphology, and 3 
related to immune responses. For TE, there were 6 func-
tions predicted to change in response to CSF2 and all 
were predicted to decrease. These functions were related 
to antibody response, quantity of cells and cell migration, 
and dermatitis. Three transcription factors were pre-
dicted to be activated by CSF2 in ICM (HLX, IKZF1, and 
ZNF217) while 13 were predicted to be inhibited (HSF1, 
STAT3, SRF, STAT4, CREM, SP1, CREB1, FOXM1, ERG, 
ETS1, SMARCA4, CREBBP and CTNNB1) (Additional 
file 3). Only two transcription factors were predicted to 
be activated by CSF2 in TE (SATB1 and NFATC2) and 
none were predicted to be inhibited.
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Comparison to genes regulated by CSF2 in bovine morulae 
and mouse blastocysts
The set of genes regulated by CSF2 in the ICM and TE 
were compared to sets of genes previously reported to 
be regulated by CSF2 in embryos. In an earlier experi-
ment with bovine embryos, Loureiro el al. [7] identi-
fied 67 genes in Day 6 morula that were upregulated by 
CSF2 treatment at Day 5 and 92 genes that were down-
regulated. Of these 159 genes, only 7 were regulated 
by CSF2 in a similar manner for Day 8 blastocysts. Of 
genes upregulated by CSF2 in morula, SLC26A5 was 
upregulated in ICM, ANKRD37 was upregulated in TE, 
and PYGO1 was upregulated in ICM and TE. Of genes 
downregulated in morula, DTX3 and VGLL1 were down-
regulated in ICM and NEDD4 and PHGDH were down-
regulated in TE.
In another experiment, Chin et  al. [17] identified 16 
genes related to stress responses that were downregu-
lated in mouse blastocysts treated with CSF2. Two of 
these genes, DFF5 and HSPH1, were also downregulated 
in ICM in the current experiment.
Discussion
CSF2 can have multiple effects on the function of the 
developing bovine embryo. These include increased 
potential to develop to the blastocyst stage [4–6], reduced 
apoptosis [7], and enhanced ability of ICM to remain 
pluripotent after culture [6]. As a result of these or other 
actions, embryos treated with CSF2 have increased abil-
ity to develop to term after transfer to recipients [8, 9]. 
Accordingly, CSF2 could be a useful molecule for com-
mercial production of bovine embryos based on in vitro 
fertilization and culture. In the current study, it was 
shown that effects of CSF2 on embryonic function are 
accompanied by changes in gene expression in both the 
ICM and TE of the blastocyst. Moreover, the actions of 
CSF2 on gene expression were largely distinct for the two 
cell types. Of 1782 genes regulated by CSF2  >  1.5-fold, 
Table 1 Genes regulated by CSF2 in inner cell mass after adjustment for a false discovery rate of 2 %
Gene symbol or description Mean counts,  
control
Mean counts,  
CSF2
Fold change,  
CSF2/control
Adjusted 
P value
Upregulated
 FRMPD3 1.4 21.3 14.71 0.045
 NDNF 1.7 22.8 13.29 0.019
 LAPTM5 43.3 531.8 12.28 0.000
 Olfactory receptor 4A47 (LOC100294956) 4.4 37.2 8.48 0.014
 CYP3A5 37.3 230.9 6.20 0.000
 Serine incorporator 1 pseudogene (LOC781002) 25.2 152.2 6.05 0.000
 TMEM182 17.8 83.6 4.69 0.014
 CSN3 97.6 444.2 4.55 0.000
Downregulated
 MYADM‑like (ENSBTAG00000001526) 10.2 0 – 0.006
 CD68 1156.8 491.9 0.43 0.024
 CFAP54 162.4 69.2 0.43 0.026
 DAG1 345.6 141.4 0.41 0.026
 HSD3B1 183.6 71.7 0.39 0.002
 EKC/KEOPS complex subunit LAGE3 (LOC618023) 87.4 29.9 0.34 0.019
 SEMA4G 127.1 42.5 0.33 0.026
 BAG3 835.4 204.9 0.25 0.028
 PAQR7 187.9 31.5 0.17 0.013
 PAH 56.2 8.8 0.16 0.012
 MUC3A 79.6 12.4 0.16 0.014
 SOX30 85.3 12.6 0.15 0.013
 HSPA6 240.0 29.3 0.12 0.000
 SYNE2 635.1 76.7 0.12 0.000
 OR5T2 88.6 10.1 0.11 0.000
 Olfactory receptor, family 5, subfamily T‑like  
(ENSBTAG00000039348)
11.7 0.6 0.05 0.046
 CMYA5 38.5 2.0 0.05 0.006
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only 49 genes were regulated by CSF2 in the same direc-
tion in both cell types. Thus, differentiation of the blas-
tocyst is such that, by Day 8 after fertilization, the ICM 
and TE respond differently to maternal signals. Analy-
sis of the genes regulated by CSF2 in ICM and TE are 
suggestive that CSF2 reinforces developmental fate and 
function of both cell lineages. Actions of CSF2 on the 
ICM reduced expression of genes in signaling pathways 
involved in differentiation while actions of CSF2 on the 
TE reduced expression of genes in pluripotency pathways 
Table 2 Genes regulated by CSF2 in trophectoderm after adjustment for a false discovery rate of 2 %
Gene symbol or description Mean counts, 
control
Mean counts,  
CSF2
Fold change,  
CSF2/control
Adjusted  
P value
Upregulated
 CLIC6 0 6.7 – 0.025
 OR5AN1 0.6 9.7 16.22 0.021
 CSN3 42.4 554.8 13.08 0.000
 Uncharacterized (ENSBTAG00000033304) 11.1 127.5 11.46 0.000
 Exocyst complex component 1‑like (LOC100335745) 1.2 9.9 8.09 0.049
 Uncharacterized (ENSBTAG00000040552) 2.9 20.8 7.19 0.012
 HPCAL4 427.9 2667.1 6.23 0.000
 CCDC146 12.9 70.3 5.43 0.000
 DEAD/H box polypeptide 26B‑like (LOC100138355) 7.4 34.9 4.72 0.002
 Uncharacterized (LOC100335677) 17.2 68.7 3.99 0.012
 TKTL1 64.6 205.7 3.18 0.001
 FOS 344.1 775.3 2.25 0.042
 DUSP1 897.1 1959.3 2.18 0.008
 SHE 216.5 445.6 2.06 0.018
Downregulated
 SLC25A40‑like (LOC510700) 451.6 179.4 0.40 0.045
 AKAP4 104.7 30.0 0.29 0.004
 MUC1 284.2 73.8 0.26 0.000
 VAV3 43.1 10.3 0.24 0.003
 VAV3 52.6 11.5 0.22 0.002
 VAV3 34.1 7.0 0.21 0.001
 PAQR7 341.6 20.1 0.06 0.000
 NPY1R 333.9 18.8 0.06 0.000
 Interferon regulatory factor‑like (ENSBTAG00000031214) 26.4 1.4 0.05 0.000
Table 3 SuperPaths overrepresented among genes downregulated in the inner cell mass by CSF2
Shown are those SuperPaths that were highly significant (P < 0.001). Note that there were no SuperPaths identified in the list of genes upregulated in the ICM by CSF2
ERK signaling (score = 22.99)—51 genes
 ACTA2, ACTG2, ADCY8, ALK, ARHGDIB, ARHGEF6, CACNB3, CACNA1G, CCL5, CDH2, CDH9, COL1A1, DES, EFEMP1, EPHA3, ESR2, FGF16, FOSB, FOSL1, GNA11, 
GNA12, GNAT2, IL11RA, IL12RB2, IL15RA, IL20, IL4, IL7, IRAK1, LEF1, MAPK12, MYH1, MYLPF, MYO18B, MYO7A, MUC1, MYC, NCAN, PAK3, PPP1R3C, SEMA4G, 
SMAD9, SOX11, SOX30, STAT6, TGFBR3, TIMP2, TNFAIP6, TNFSF9, TNFSF11, VIM
Integrin pathway (score = 16.42)—28 genes
 ACTA2, ACTG2, ADCY8, ARHGEF6, CACNA1G, CACNB3, CAV1, CCL5, CLDN1, COL1A1, EFEMP1, GNA11, GNA12, GNAT2, MAPK13, MMP9, MYC, MYH1, MYLPF, 
MYO18B, MYO7A, NCAN, NOX1, PAK3, STAT6, TGFBR3, THBS1, VAV3
Visual cycle (score = 14.74)—10 genes
 GNA11, GNA12, GNAT2, GUCA1A, GUCY2C, LRAT, PDE6A, RDH10, RDH12, SLC24A1
Akt signaling (score = 14.45)—30 genes
 ACTA2, ACTG2, AKR1B1, ALK, ATXN7, CCL5, EPHA3, FGF16, FOSL1, GABRG1, GNA11, GNA12, GNAT2, IL11RA, IL12RB2, IL15RA, IL20, IL4, IL7, IRAK1, MAPK13, PAK3, 
SEMA4G, STAT6, TIMP2, TLR7, TNFAIP6, TNFSF11, TNFSF9, VAV3
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and may have increased capacity of the TE to interact 
with the maternal system through upregulation of genes 
involved in extracellular processes.
Many of the genes regulated by CSF2 in the ICM are 
involved in signal transduction. The three significant 
annotation clusters in which genes regulated by CSF2 
were overrepresented are related to membrane signal-
ing. The overall picture is for downregulation of genes 
involved in signal transduction, particularly for the ERK/
MAPK and AKT signaling pathways. Repression of 
Table 4 SuperPaths overrepresented among genes upregulated in the trophectoderm by CSF2
Shown are those SuperPaths that were highly significant (P < 0.001)
Inhibitory actions of lipoxins on superoxide production in neutrophils (score = 25.39)—9 genes
 FOS, GNG12, GNG2, GNGT2, JUN, PLD1, NFKBIA, PIK3CG, PREX1
Translation regulation by alpha‑1 adrenergic receptors (score = 19.66)—8 genes
 ADRA1A, FOS, GNG12, GNG2, GNGT2, JUN, PLD1, PRKCE
Hypertrophy model (score = 18.66)—5 genes
 ANKRD1, ATF3, CYR61, HBEGF, IFNG
Apoptotic pathways in synovial fibroblasts (score = 16.29)—22 genes
 ANK1, ARHGDIB, CACNA2D1, CTGF, FOS, GNG12, GNG2, GNGT2, HBEGF, ITGB3, JUN, KITLG, KLF10, MAP3K8, NFKBIA, NRP1, PLD1, PPARA, PPP1R14A, PRKCE, 
RHOB, ZAP70
G‑protein signaling ras family gtpases in kinase cascades (score = 15.90) 8 genes
 CYR61, FOS, FOSB, JUN, LDLR, NFKBIA, PRKCE, SIPA1
Toll comparative pathway (score = 15.54) 8 genes
 ATF3, FOS, FOSB, GNG2, IFNG, IL1RAP, JUN, NFKBIA
ERK signaling (score = 15.12) 29 genes
 ARHGDIB, ATF3, CACNA2D1, CAPN11, CTGF, DUSP1, FOS, FOSB, GNG12, GNG2, GNGT2, HBEGF, IL17A, ITGB3, JUN, KITLG, KLF10, MAP3K8, NFKBIA, NRP1, PIK3CG, 
PLD1, PPP1R14A, PRKCE, RHOB, SMAD9, SPP1, TNFRSF8, ZAP70
Osteopontin‑mediated events (score = 15.0)—5 genes
 FOS, ITGB3, JUN, NFKBIA, SPP1
ATF‑2 transcription factor network (score = 14.65)—6 genes
 ATF3, DUSP1, DUSP5, FOS, IFNG, JUN
Angiotensin activation of ERK (score = 14.51)—11 genes
 FOS, GNG12, GNG2, GNGT2, HBEGF, KITLG, ITGB3, JUN, PIK3CG, PRKCE, ZAP70
LPA receptor mediated events (score = 13.79)—6 genes
 FOS, GNG2, HBEGF, JUN, NFKBIA, PRKCE
Table 5 SuperPaths overrepresented among genes downregulated in the trophectoderm by CSF2
Shown are those SuperPaths that were highly significant (P < 0.001) as well as two selected pathways that were P < 0.05 (TGF-BETA and Nanog in Mammalian ESC 
pluripotency)
CREB Pathway (score = 17.43)—22 genes
 ARHGEF6, AXL, BMP3, CACNA2D3, CACNG6, CLU, EPHA3, EPHB3, FLT1, FLT3, GNA14, GNB5, GNRH1, GRID2, HTR3E, PDE1C, PRKCH, SEMA5A, SLC8A2, TEK, THPO, 
VAV3
Actin Nucleation by ARP‑WASP Complex (score = 14.94)—16 genes
 ARHGEF6, AXL, EPHA3, EPHB3, FLT1, FLT3, GNA14, GNB5, ITGAE, ITGB6, LPAR1, LPAR3, MYH1, MYH7, MYO7A, TEK
Akt Signaling (score = 14.53)—24 genes
 AXL, BMP15, BMP3, CCL17, CD28, CD80, EPHA3, EPHB3, FCER1G, FLT1, FLT3, GNA14, GNB5, GNRH1, IL10, ITGAE, ITGB6, PRKCH, PXDN, SEMA5A, TEK, THPO, 
TNFSF8, VAV3
ERK Signaling (score = 14.11)—34 genes
 ARHGEF6, AXL, BMP15, BMP3, CACNA2D3, CACNG6, CCL17, CD28, CD80, CDH13, ECM2, EPHA3, EPHB3, FBN1, FLT1, FLT3, GNA14, GNB5, GNRH1, IL10, ITGAE, 
ITGB6, LAMA4, MUC1, MYC, MYH1, MYH7, MYO7A, PRKCH, PXDN, SEMA5A, TEK, THPO, TNFSF8
TGF‑BETA (score = 11.30) 21 genes
 ARHGEF6, AXL, BMP15, BMP3, CCL17, CD80, EPHA3, EPHB3, FLT1, FLT3, GNA14, GNB5, GNRH1, IL10, ITGAE, ITGB6, MYC, PXDN, SEMA5A, TEK, THPO
Nanog in mammalian ESC pluripotency (score = 9.82)—17 genes
 AQP2, AXL, BMP3, CDH13, EPHA3, EPHB3, FLT1, FLT3, GNB5, GNRH1, LPAR1, LPAR3, PRKCH, SEMA5A, TEK, THPO, WNT8B
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MAPK signaling by CSF2 may facilitate maintenance of 
the ICM in a pluripotent condition. In cattle, inhibition 
of MAPK signaling increases numbers of cells positive 
for NANOG while reducing expression of the TE gene 
IFNT and cells positive for the hypoblast marker GATA6 
[18, 19]. Inhibition of MAPK also promotes formation 
of naïve-type induced pluripotent stem cells in the cow 
[20]. Downregulation of genes involved in AKT signaling 
would counteract the downregulation of MAPK signaling 
because this pathway can itself inhibit MAPK signaling 
[21]. However, inhibition of PI3K (upstream regulator of 
AKT) did not affect expression of pluripotency-related 
genes in the bovine blastocyst although ICM numbers 
were reduced [22]. CSF2 can signal through the phos-
phatidylinositol 3-kinase/AKT pathway [23] and down-
regulation of expression of genes in the AKT pathway by 
CSF2 could reflect feedback inhibition. Three transcrip-
tion factors that are involved in actions of CSF2 in other 
cells, CTTNB1, SP1, and STAT3 [24, 25], were also pre-
dicted to be inhibited in the ICM by CSF2.
Another indication that CSF2 promotes maintenance 
of the ICM in a pluripotent state was the observation 
that the transcription factor ETS1 was predicted to be 
inhibited in the ICM. ETS1 promotes differentiation of 
human trophoblast [26] and a related molecule, ETS2, is 
involved in transcriptional regulation of trophoblast spe-
cific genes like IFNT and TKDP1 [27]. Another transcrip-
tional regulator predicted to be inhibited by CSF2 in the 
ICM, STAT3, is important for formation of the ICM and 
expression of pluripotency markers in cattle [22] while 
another, CREBBP participates in downregulation of the 
trophoblast gene IFNT [28].
The TE is the cell type in the blastocyst that interacts 
most closely with the maternal reproductive tract, both 
because of its location at the outer boundaries of the 
embryo and because tight junctions between TE cells 
[29] limit movement of molecules from the ICM to the 
extra-embryonic space. CSF2 may facilitate interactions 
between the TE and maternal cells because genes regu-
lated by CSF2 in the TE included a large cluster of genes 
related to secreted or extracellular proteins. Among the 
genes whose expression in TE was downregulated by 
CSF2 was MUC1, which encodes for a mucin that inhib-
its adhesion to cell surfaces. MUC1 is present on human 
trophoblast and overexpression in the Jar trophoblast cell 
line reduced invasiveness of the cells [30]. Perhaps inhi-
bition of MUC1 expression by CSF2 increases the com-
petence of the TE to interact with the endometrium. In 
addition, MUC1 can participate in cell signaling because 
its cytoplasmic tail can regulate β-catenin stability [31].
One gene whose expression in TE was increased by 
CSF2 was FOS. The promoter for the maternal recogni-
tion of pregnancy protein, IFNT, contains an AP1 site 
[32] and deletions in that site can decrease IFNT1 gene 
expression [27]. Treatment of embryos with CSF2 from 
Day 5–7 caused an increase in IFNT accumulation in the 
uterus at Day 15 of pregnancy for male embryos [33] and 
it is possible that regulation of FOS is involved in this 
action of CSF2. If so, effects of CSF2 could be sex-spe-
cific because CSF2 decreased IFNT accumulation in the 
uterus of cows that received female embryos [33].
CSF2 may also promote differentiation of the TE. 
Unlike for the mouse, the TE of the bovine embryo only 
gradually becomes committed to the TE fate and, when 
aggregated with 8-cell embryos, some TE cells from 
the day 7 blastocyst can revert to ICM [34]. Several 
genes downregulated by CSF2 in TE were identified as 
members of the Nanog and TGF-β signaling pathways. 
NANOG is a well-described promoter of pluripotency 
in the ICM [35] and TGF-β signaling has been reported 
to promote pluripotency in human embryonic stem 
cells [36] but to reduce epiblast formation in the mouse 
embryo [37].
One of the surprising set of signaling genes regulated by 
CSF2 in the ICM was that for olfactory receptors. Some 
of these genes were increased in expression by CSF2 and 
others decreased. Several olfactory receptors were also 
regulated by CSF2 in the TE including OR5AN1, which 
was increased 16-fold by CSF2 (Table  2). Olfactory 
receptors are a large gene family. A total of 1071 olfactory 
receptor related sequences were identified in the bovine 
genome including 881 functional genes with the remain-
der being pseudogenes or partial sequences [38]. The fact 
that specific olfactory receptors are regulated by CSF2 
implies that olfactory receptor signaling may be impor-
tant for embryonic development and that actions of spe-
cific odorants on the embryo could be modified by CSF2.
CSF2 is best known for its role in the immune system, 
where in addition to promoting formation of granulo-
cytes and macrophages from hematopoietic stem cells, 
it also controls neutrophil function and macrophage 
differentiation [39, 40]. Regulation of genes involved in 
immune function by CSF2 in the embryo accounts for 
the observation that many of the functions predicted 
to change in response to CSF2 were related to immune 
function.
The finding that the genes regulated by CSF2 in the 
ICM were distinct from those regulated by CSF2 in the 
TE strengthens the idea that transcriptional regulation by 
CSF2 depends on cell type. In addition, the genes regu-
lated by CSF2 in the ICM and TE were largely different 
than those found to be regulated by CSF2 in the bovine 
morula [7]. The 7 genes that were regulated similarly by 
CSF2 in morula and blastocysts include 3 upregulated 
genes (ANKRD37, a putative nuclear localization signal, 
PYGO1, a coactivator of transcription of WNT-regulated 
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genes, and SLC26A5, an incomplete anion transporter 
involved in changing cell shape) and 4 downregulated 
genes (DTX3 and NEDD4, both involved in ubiquitina-
tion, PHGDH, an enzyme involved in serine synthesis, 
and VGLL1, a coactivator of transcription factors). In the 
bovine, activation of WNT signaling either reduced [41, 
42] or increased [41] competence of embryos to become 
blastocysts and preferentially reduced number of TE cells 
as compared to ICM cells [42]. Deubiquitinating enzymes 
are required for blastocyst formation in mice and pigs 
[43]. Serine is probably not a major energy source for 
the bovine embryo because it is not taken up by blasto-
cysts to a large degree [44] and addition of the amino acid 
to culture medium of bovine embryos had no effect on 
development to the blastocyst stage [45].
Conclusions
CSF2 can cause differential actions on gene expression in 
the ICM and TE. One interpretation of changes in gene 
expression is that CSF2 reinforces the lineage commit-
ment decisions in ICM and TE and enhances ability of 
the TE to communicate with the maternal reproductive 
tract. Additional functional studies will be required to 
test these hypotheses.
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